We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M Turnover 20%
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$536M
AUM Growth
+$200M
Cap. Flow
+$203M
Cap. Flow %
37.93%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
1
Closed
–
Avg Time Held
1.9 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
1.9 years

Top Buys

Rank Stock Value
1
DYN icon
Dyne Therapeutics
DYN
+$109M
2
ITOS icon
iTeos Therapeutics
ITOS
+$99.7M

Top Sells

Rank Stock Value
1
SNDX icon
Syndax Pharmaceuticals
SNDX
+$4.96M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
DYN icon
1
Dyne Therapeutics
DYN
$2.81B
$100M 18.64%
+4,951,303
New +$109M
2020 Q3
0 quarters
RPTX icon
2
DELISTED
Repare Therapeutics
RPTX
$92.4M 17.24%
3,003,772
– –
2020 Q2
1 quarter
ITOS icon
3
DELISTED
iTeos Therapeutics
ITOS
$91.4M 17.05%
+3,706,663
New +$99.7M
2020 Q3
0 quarters
TCRR
4
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$82.3M 15.35%
4,050,865
– –
2019 Q1
6 quarters
HARP
5
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$76.9M 14.33%
452,443
– –
2019 Q1
6 quarters
RYTM icon
6
Rhythm Pharmaceuticals
RYTM
$5.97B
$41.4M 7.72%
1,909,258
– –
2017 Q4
11 quarters
SNDX icon
7
Syndax Pharmaceuticals
SNDX
$1.21B
$27.2M 5.07%
1,843,388
-325,303
-15% -$4.96M
2016 Q1
18 quarters
CHMA
8
DELISTED
Chiasma, Inc. Common Stock
CHMA
$24.7M 4.6%
5,736,296
– –
2015 Q3
20 quarters

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, MPM Asset Management held 8 positions worth $536M, up 60% from $336M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management deployed $203M of net new capital in Q3 2020, opening 2 new positions. Its largest new stake was Dyne Therapeutics: 4,951,303 shares worth $100M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Syndax Pharmaceuticals, an estimated $4.96M trimmed.

  • MPM Asset Management's largest Q3 2020 buy was Dyne Therapeutics: 4,951,303 shares worth $100M.
  • MPM Asset Management's biggest Q3 2020 reduction was Syndax Pharmaceuticals, cutting an estimated $4.96M.
  • MPM Asset Management's ten largest holdings make up 100% of its $536M portfolio in Q3 2020.
  • MPM Asset Management opened 2 new positions and closed 0 in Q3 2020.
  • MPM Asset Management's portfolio value rose 60% quarter-over-quarter to $536M.

Based on MPM Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.